Actively Recruiting
Carbofix Pedicle Screw System Randomized Trial Comparing Carbon Fiber and Titanium Implants in Spinal Fusion for Degenerative Spinal Diseases
Led by Istituto Ortopedico Rizzoli · Updated on 2025-01-17
118
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the clinical and radiographic outcomes of using a carbon fiber pedicle screw system compared to traditional titanium devices in patients undergoing spinal fusion surgery for degenerative spinal diseases. This study focuses on adults with degenerative disc disease or spondylolisthesis who require stabilization of one or two lumbar or lumbosacral levels. The rationale includes the potential advantages of carbon fiber devices, such as minimal interference with radiotherapy and improved imaging visibility compared to titanium devices. Participants will receive spinal stabilization using either CarboFix carbon fiber screws and rods or titanium screws and rods. The study involves a randomized clinical trial design comparing these two procedures. The primary outcome measure is the fusion rate assessed throughout the study, which lasts an average of one year. No other treatment details or extension phases are described. During the study, participants will be monitored for fusion success and undergo clinical and radiographic evaluations. Follow-up visits will assess the stability and healing of the spinal fusion. Participants are required to understand and sign informed consent and comply with follow-up schedules. The total duration of participation is approximately one year, focusing on the effectiveness and imaging outcomes of the two types of spinal stabilization devices.
CONDITIONS
Official Title
Carbofix Pedicle Screw System: Evaluation of the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels
- Age greater than or equal to 18 years
- Ability to understand and sign the informed consent to the study and to follow the required follow-ups
You will not qualify if you...
- Metabolic bone disease
- History of Paget's disease or other osteodystrophies, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia
- Neoplastic disease
- History of mental disorder or current psychiatric treatment
- Pregnancy
- Immunodeficiency diseases
- Infectious bone disease (discitis, osteomyelitis)
- Treatment with drugs that can interfere with bone metabolism
- Inability to understand and sign the informed consent to the study and to follow the required follow-up visits
- Alcohol and/or drug abuse
- Obesity
- Metal allergy
- Participation in other studies on drugs or devices within 30 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136
Actively Recruiting
Research Team
A
Alessandro Gasbarrini, MD
C
Cristiana Griffoni, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2